Quarterly Call Option Transactions in Uro Gen Pharma Ltd. (URGN)
This table provides information about the institutional ownership of Uro Gen Pharma Ltd. (URGN) during . The information is specifically focused on institutions that hold call options of UroGen Pharma Ltd..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2022 | 0 | 41,400 | 41,400 | — | 41,400 | |||
| Q4 2022 | 96,300 | 100 | 96,400 | — | 96,400 | |||
| Q1 2023 | 400 | 0 | 400 | 46,400 | 0 | 46,400 | -46,000 | |
| Q2 2023 | 0 | 2,400 | 2,400 | 45,700 | 0 | 45,700 | -43,300 | |
| Q3 2023 | 17,400 | 15,700 | 33,100 | — | 33,100 | |||
| Q4 2023 | — | 6,700 | 0 | 6,700 | -6,700 | |||
| Q1 2024 | 1,400 | 24,500 | 25,900 | — | 25,900 | |||
| Q2 2024 | 37,600 | 73,700 | 111,300 | — | 111,300 | |||
| Q3 2024 | — | 62,500 | 0 | 62,500 | -62,500 | |||
| Q4 2024 | 47,900 | 0 | 47,900 | — | 47,900 | |||
| Q1 2025 | 13,500 | 20,200 | 33,700 | — | 33,700 | |||
| Q2 2025 | 569,700 | 1,395,300 | 1,965,000 | — | 1,965,000 | |||
| Q3 2025 | 950,100 | 40,000 | 990,100 | 264,200 | 0 | 264,200 | 725,900 | |